Gauging how healthcare payers and pharmaceutical manufacturers are reacting to the Inflation Reduction Act of 2022
Inflation Reduction Act Payer Insights:
Understand How Healthcare Payers are Adapting
The 2022 IRA Payer Insights Survey by Magnolia Market Access dives deep into how top healthcare payers and PBMs covering over 290 million lives are responding to the Inflation Reduction Act’s transformative policies. This report offers critical insights into how the IRA’s Medicare Drug Price Negotiation Program, inflation penalties, and Part D redesign are reshaping the industry.
Get exclusive insights on:
- Medicare-driven drug price impacts: How payers anticipate lower prices and prioritize net cost
- Cost-control measures: Strategies like increased utilization management, tighter formularies, and larger manufacturer rebates
- Payer perspectives on manufacturer responses: Including increased launch prices and outcomes-based contracting trends
Download the full report to stay informed and prepared for these pivotal industry changes driven by the IRA.
